Stocks and Investing Stocks and Investing
Thu, March 7, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Casey Alexander Downgraded (TPVG) to Strong Sell and Held Target at $8.75 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Thomas Poutrieux Upgraded (TOST) to Buy and Held Target at $30 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Kevin Kopelman Maintained (TCOM) at Buy with Increased Target to $53 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Peter Lawson Maintained (TCRX) at Buy with Increased Target to $9 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Andrew Fein Reiterated (TCRX) at Strong Buy and Held Target at $15 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Nik Modi Reiterated (STZ) at Buy and Held Target at $295 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Mark Lear Maintained (STR) at Buy with Increased Target to $27 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Kevin Steinke Maintained (SUP) at Buy with Increased Target to $11 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Sean Dodge Reiterated (SRCL) at Buy and Held Target at $69 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
David Barden Downgraded (CCOI) to Hold and Decreased Target to $75 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Sean Dodge Reiterated (CDMO) at Buy and Held Target at $7 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Andrew Charles Maintained (YUM) at Buy with Increased Target to $160 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Gregory Francfort Maintained (YUM) at Strong Buy with Increased Target to $155 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Naved Khan Maintained (YEXT) at Hold with Decreased Target to $8 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Andrew Fein Maintained (WVE) at Strong Buy with Increased Target to $15 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Luca Issi Reiterated (WVE) at Hold and Held Target at $5 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Mitch Germain Reiterated (WSR) at Buy and Held Target at $15 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Oren Livnat Maintained (XERS) at Strong Buy with Increased Target to $6 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Jason Seidl Maintained (XPO) at Buy with Increased Target to $136 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Edward Kelly Maintained (UNFI) at Sell with Decreased Target to $12 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Bill Kirk Reiterated (UNFI) at Hold with Decreased Target to $13 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Kevin Fischbeck Maintained (UNH) at Strong Buy and Held Target at $675 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Joshua Chan Maintained (ABM) at Hold with Increased Target to $45 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Judah Frommer Initiated (ACLX) at Buy and Held Target at $81 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Jason Kupferberg Maintained (ACN) at Strong Buy with Increased Target to $419 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
David Koning Maintained (ACN) at Hold with Increased Target to $375 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Vijay Rakesh Maintained (ARM) at Strong Buy with Increased Target to $160 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Praneeth Satish Maintained (ARIS) at Hold with Increased Target to $11 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Joseph Feldman Reiterated (ARHS) at Buy and Held Target at $15 on, Mar 7th, 2024
[ Thu, Mar 07th 2024 ] - WOPRAI
Thomas Flaten Maintained (AQST) at Strong Buy with Increased Target to $8 on, Mar 7th, 2024

Thomas Flaten Maintained (AQST) at Strong Buy with Increased Target to $8 on, Mar 7th, 2024


Published on 2024-10-28 09:32:12 - WOPRAI, Thomas Flaten
  Print publication without navigation


Thomas Flaten of Lake Street, Maintained "Aquestive Therapeutics, Inc." (AQST) at Strong Buy with Increased Target from $3 to $8 on, Mar 7th, 2024.

Thomas has made no other calls on AQST in the last 4 months.



There is 1 other peer that has a rating on AQST. Out of the 1 peers that are also analyzing AQST, 0 agree with Thomas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Thomas

  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $6 on, Wednesday, November 8th, 2023
Contributing Sources